Neoadjuvant Chemoradiotherapy With Sequential Ipilimumab and Nivolumab in Rectal Cancer
Clinical trial NCT04124601 · COMPLETED
Trial details
- NCT number
- NCT04124601
- Sponsor
- Johannes Laengle, MD, PhD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2024-03-15
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.